Left  ||| S:0 E:5 ||| VBN
ventricular  ||| S:5 E:17 ||| JJ
hypoplasia ||| S:17 E:27 ||| NN
:  ||| S:27 E:29 ||| :
a  ||| S:29 E:31 ||| DT
spectrum  ||| S:31 E:40 ||| NN
of  ||| S:40 E:43 ||| IN
disease  ||| S:43 E:51 ||| NN
involving  ||| S:51 E:61 ||| VBG
the  ||| S:61 E:65 ||| DT
left  ||| S:65 E:70 ||| JJ
ventricular  ||| S:70 E:82 ||| JJ
outflow  ||| S:82 E:90 ||| NN
tract ||| S:90 E:95 ||| NN
,  ||| S:95 E:97 ||| ,
aortic  ||| S:97 E:104 ||| JJ
valve ||| S:104 E:109 ||| NN
,  ||| S:109 E:111 ||| ,
and  ||| S:111 E:115 ||| CC
aorta  ||| S:115 E:121 ||| JJ
Hypoplastic  ||| S:121 E:133 ||| NNP
left  ||| S:133 E:138 ||| VBD
heart  ||| S:138 E:144 ||| NN
syndrome  ||| S:144 E:153 ||| NN
is  ||| S:153 E:156 ||| VBZ
an  ||| S:156 E:159 ||| DT
unsatisfactory  ||| S:159 E:174 ||| JJ
term  ||| S:174 E:179 ||| NN
describing  ||| S:179 E:190 ||| VBG
lethal  ||| S:190 E:197 ||| JJ
underdevelopment  ||| S:197 E:214 ||| NN
of  ||| S:214 E:217 ||| IN
the  ||| S:217 E:221 ||| DT
left  ||| S:221 E:226 ||| JJ
ventricle  ||| S:226 E:236 ||| NNS
( ||| S:236 E:237 ||| -LRB-
LV ||| S:237 E:239 ||| NNP
) ||| S:239 E:240 ||| -RRB-
.  ||| S:240 E:242 ||| .
It  ||| S:242 E:245 ||| PRP
represents  ||| S:245 E:256 ||| VBZ
the  ||| S:256 E:260 ||| DT
more  ||| S:260 E:265 ||| RBR
severe  ||| S:265 E:272 ||| JJ
end  ||| S:272 E:276 ||| NN
of  ||| S:276 E:279 ||| IN
a  ||| S:279 E:281 ||| DT
spectrum  ||| S:281 E:290 ||| NN
of  ||| S:290 E:293 ||| IN
LV  ||| S:293 E:296 ||| NNP
hypoplasia ||| S:296 E:306 ||| NN
,  ||| S:306 E:308 ||| ,
mandating  ||| S:308 E:318 ||| VBG
single-ventricle  ||| S:318 E:335 ||| JJ
palliation  ||| S:335 E:346 ||| NN
or  ||| S:346 E:349 ||| CC
cardiac  ||| S:349 E:357 ||| JJ
transplantation ||| S:357 E:372 ||| NN
.  ||| S:372 E:374 ||| .
Less  ||| S:374 E:379 ||| RBR
severe  ||| S:379 E:386 ||| JJ
borderline  ||| S:386 E:397 ||| JJ
ventricular  ||| S:397 E:409 ||| JJ
hypoplasia  ||| S:409 E:420 ||| NN
may  ||| S:420 E:424 ||| MD
instead  ||| S:424 E:432 ||| RB
allow  ||| S:432 E:438 ||| VB
various  ||| S:438 E:446 ||| JJ
biventricular  ||| S:446 E:460 ||| JJ
therapeutic  ||| S:460 E:472 ||| JJ
strategies  ||| S:472 E:483 ||| NNS
and  ||| S:483 E:487 ||| CC
better  ||| S:487 E:494 ||| RBR
long-term  ||| S:494 E:504 ||| JJ
outcomes ||| S:504 E:512 ||| NNS
.  ||| S:512 E:514 ||| .
In  ||| S:514 E:517 ||| IN
this  ||| S:517 E:522 ||| DT
review ||| S:522 E:528 ||| NN
,  ||| S:528 E:530 ||| ,
we  ||| S:530 E:533 ||| PRP
consider  ||| S:533 E:542 ||| VBP
factors  ||| S:542 E:550 ||| NNS
causing  ||| S:550 E:558 ||| VBG
and  ||| S:558 E:562 ||| CC
modifying  ||| S:562 E:572 ||| VBG
the  ||| S:572 E:576 ||| DT
abnormal  ||| S:576 E:585 ||| JJ
development  ||| S:585 E:597 ||| NN
of  ||| S:597 E:600 ||| IN
the  ||| S:600 E:604 ||| DT
LV ||| S:604 E:606 ||| NNP
.  ||| S:606 E:608 ||| .
LV  ||| S:608 E:611 ||| NNP
hypoplasia  ||| S:611 E:622 ||| NN
is  ||| S:622 E:625 ||| VBZ
typically  ||| S:625 E:635 ||| RB
seen  ||| S:635 E:640 ||| VBN
in  ||| S:640 E:643 ||| IN
association  ||| S:643 E:655 ||| NN
with  ||| S:655 E:660 ||| IN
left  ||| S:660 E:665 ||| VBN
ventricular  ||| S:665 E:677 ||| JJ
outflow  ||| S:677 E:685 ||| NN
tract  ||| S:685 E:691 ||| NN
obstruction ||| S:691 E:702 ||| NN
,  ||| S:702 E:704 ||| ,
itself  ||| S:704 E:711 ||| PRP
part  ||| S:711 E:716 ||| NN
of  ||| S:716 E:719 ||| IN
a  ||| S:719 E:721 ||| DT
spectrum  ||| S:721 E:730 ||| NN
of  ||| S:730 E:733 ||| IN
related  ||| S:733 E:741 ||| JJ
defects  ||| S:741 E:749 ||| NNS
with  ||| S:749 E:754 ||| IN
common  ||| S:754 E:761 ||| JJ
etiologies ||| S:761 E:771 ||| NN
.  ||| S:771 E:773 ||| .
Secondary  ||| S:773 E:783 ||| JJ
responses  ||| S:783 E:793 ||| NNS
to  ||| S:793 E:796 ||| TO
outflow  ||| S:796 E:804 ||| VB
obstruction  ||| S:804 E:816 ||| NNS
are  ||| S:816 E:820 ||| VBP
complex  ||| S:820 E:828 ||| JJ
but  ||| S:828 E:832 ||| CC
involve  ||| S:832 E:840 ||| VB
abnormal  ||| S:840 E:849 ||| JJ
flow  ||| S:849 E:854 ||| NN
dynamics  ||| S:854 E:863 ||| NNS
and  ||| S:863 E:867 ||| CC
shear  ||| S:867 E:873 ||| NN
stresses  ||| S:873 E:882 ||| VBZ
that  ||| S:882 E:887 ||| DT
result  ||| S:887 E:894 ||| NN
in  ||| S:894 E:897 ||| IN
compromised  ||| S:897 E:909 ||| NN
and  ||| S:909 E:913 ||| CC
poorly  ||| S:913 E:920 ||| RB
orchestrated  ||| S:920 E:933 ||| VBN
ventricular  ||| S:933 E:945 ||| JJ
growth  ||| S:945 E:952 ||| NN
and  ||| S:952 E:956 ||| CC
development ||| S:956 E:967 ||| NN
.  ||| S:967 E:969 ||| .
Subsequent  ||| S:969 E:980 ||| JJ
remodeling  ||| S:980 E:991 ||| NN
is  ||| S:991 E:994 ||| VBZ
likely  ||| S:994 E:1001 ||| RB
influenced  ||| S:1001 E:1012 ||| VBN
by  ||| S:1012 E:1015 ||| IN
genetic  ||| S:1015 E:1023 ||| JJ
modifiers ||| S:1023 E:1032 ||| NN
,  ||| S:1032 E:1034 ||| ,
including  ||| S:1034 E:1044 ||| VBG
intrinsic  ||| S:1044 E:1054 ||| JJ
myocardial  ||| S:1054 E:1065 ||| JJ
growth  ||| S:1065 E:1072 ||| NN
signaling  ||| S:1072 E:1082 ||| VBG
pathways ||| S:1082 E:1090 ||| NN
,  ||| S:1090 E:1092 ||| ,
possibly  ||| S:1092 E:1101 ||| RB
including  ||| S:1101 E:1111 ||| VBG
those  ||| S:1111 E:1117 ||| DT
of  ||| S:1117 E:1120 ||| IN
HAND  ||| S:1120 E:1125 ||| NNP
transcription  ||| S:1125 E:1139 ||| NN
factors ||| S:1139 E:1146 ||| NNS
.  ||| S:1146 E:1148 ||| .
In  ||| S:1148 E:1151 ||| IN
addition ||| S:1151 E:1159 ||| NN
,  ||| S:1159 E:1161 ||| ,
during  ||| S:1161 E:1168 ||| IN
the  ||| S:1168 E:1172 ||| DT
latter  ||| S:1172 E:1179 ||| JJ
stages  ||| S:1179 E:1186 ||| NNS
of  ||| S:1186 E:1189 ||| IN
gestation ||| S:1189 E:1198 ||| NN
,  ||| S:1198 E:1200 ||| ,
cardiomyocytes  ||| S:1200 E:1215 ||| NNS
undergo  ||| S:1215 E:1223 ||| VBP
a  ||| S:1223 E:1225 ||| DT
switch  ||| S:1225 E:1232 ||| NN
in  ||| S:1232 E:1235 ||| IN
myogenic  ||| S:1235 E:1244 ||| JJ
potential  ||| S:1244 E:1254 ||| NN
and  ||| S:1254 E:1258 ||| CC
lose  ||| S:1258 E:1263 ||| VB
the  ||| S:1263 E:1267 ||| DT
ability  ||| S:1267 E:1275 ||| NN
to  ||| S:1275 E:1278 ||| TO
undergo  ||| S:1278 E:1286 ||| VB
mitosis ||| S:1286 E:1293 ||| NNS
.  ||| S:1293 E:1295 ||| .
Ventricular  ||| S:1295 E:1307 ||| JJ
hyperplasia  ||| S:1307 E:1319 ||| NN
can  ||| S:1319 E:1323 ||| MD
therefore  ||| S:1323 E:1333 ||| RB
no  ||| S:1333 E:1336 ||| RB
longer  ||| S:1336 E:1343 ||| RB
occur ||| S:1343 E:1348 ||| VB
;  ||| S:1348 E:1350 ||| :
remodeling  ||| S:1350 E:1361 ||| NN
is  ||| S:1361 E:1364 ||| VBZ
instead  ||| S:1364 E:1372 ||| RB
limited  ||| S:1372 E:1380 ||| VBN
to  ||| S:1380 E:1383 ||| TO
muscular  ||| S:1383 E:1392 ||| VB
hypertrophy ||| S:1392 E:1403 ||| NNS
.  ||| S:1403 E:1405 ||| .
Subtle  ||| S:1405 E:1412 ||| JJ
differences  ||| S:1412 E:1424 ||| NNS
in  ||| S:1424 E:1427 ||| IN
this  ||| S:1427 E:1432 ||| DT
switch  ||| S:1432 E:1439 ||| NN
in  ||| S:1439 E:1442 ||| IN
myogenic  ||| S:1442 E:1451 ||| JJ
potential--and  ||| S:1451 E:1466 ||| JJ
modulators  ||| S:1466 E:1477 ||| JJ
thereof--are  ||| S:1477 E:1490 ||| JJ
likely  ||| S:1490 E:1497 ||| JJ
to  ||| S:1497 E:1500 ||| TO
be  ||| S:1500 E:1503 ||| VB
of  ||| S:1503 E:1506 ||| IN
clinical  ||| S:1506 E:1515 ||| JJ
and  ||| S:1515 E:1519 ||| CC
therapeutic  ||| S:1519 E:1531 ||| JJ
importance ||| S:1531 E:1541 ||| NN
,  ||| S:1541 E:1543 ||| ,
especially  ||| S:1543 E:1554 ||| RB
in  ||| S:1554 E:1557 ||| IN
children  ||| S:1557 E:1566 ||| NNS
with  ||| S:1566 E:1571 ||| IN
borderline  ||| S:1571 E:1582 ||| JJ
LVs  ||| S:1582 E:1586 ||| JJ
being  ||| S:1586 E:1592 ||| VBG
considered  ||| S:1592 E:1603 ||| VBN
for  ||| S:1603 E:1607 ||| IN
fetal  ||| S:1607 E:1613 ||| JJ
interventions  ||| S:1613 E:1627 ||| NNS
or  ||| S:1627 E:1630 ||| CC
post-natal  ||| S:1630 E:1641 ||| JJ
biventricular  ||| S:1641 E:1655 ||| JJ
repair  ||| S:1655 E:1662 ||| NN
strategies ||| S:1662 E:1672 ||| NNS
.  ||| S:1672 E:1674 ||| .
Finally ||| S:1674 E:1681 ||| RB
,  ||| S:1681 E:1683 ||| ,
by  ||| S:1683 E:1686 ||| IN
more  ||| S:1686 E:1691 ||| RBR
clearly  ||| S:1691 E:1699 ||| RB
understanding  ||| S:1699 E:1713 ||| VBG
the  ||| S:1713 E:1717 ||| DT
initiators  ||| S:1717 E:1728 ||| NN
and  ||| S:1728 E:1732 ||| CC
propagators  ||| S:1732 E:1744 ||| NN
of  ||| S:1744 E:1747 ||| IN
abnormal  ||| S:1747 E:1756 ||| JJ
ventricular  ||| S:1756 E:1768 ||| JJ
development ||| S:1768 E:1779 ||| NN
,  ||| S:1779 E:1781 ||| ,
we  ||| S:1781 E:1784 ||| PRP
can  ||| S:1784 E:1788 ||| MD
hope  ||| S:1788 E:1793 ||| VB
to  ||| S:1793 E:1796 ||| TO
lean  ||| S:1796 E:1801 ||| VB
away  ||| S:1801 E:1806 ||| RP
from  ||| S:1806 E:1811 ||| IN
grouping  ||| S:1811 E:1820 ||| VBG
a  ||| S:1820 E:1822 ||| DT
heterogeneous  ||| S:1822 E:1836 ||| JJ
group  ||| S:1836 E:1842 ||| NN
of  ||| S:1842 E:1845 ||| IN
infants  ||| S:1845 E:1853 ||| NNS
together  ||| S:1853 E:1862 ||| RB
under  ||| S:1862 E:1868 ||| IN
the  ||| S:1868 E:1872 ||| DT
unsatisfactory  ||| S:1872 E:1887 ||| JJ
term  ||| S:1887 E:1892 ||| NN
hypoplastic  ||| S:1892 E:1904 ||| VBZ
left  ||| S:1904 E:1909 ||| VBN
heart  ||| S:1909 E:1915 ||| NN
syndrome ||| S:1915 E:1923 ||| NN
.  ||| S:1923 E:1925 ||| .
